<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b529d32c-e496-4bf0-8507-2f2d2601e40a,g:af049895-2a06-4151-be90-67e8a7619378-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.pharming.com/role/TagsthatmustbeappliedifcorrespondinginformationispresentinareportStatement" xlink:type="simple" xlink:href="pharm-2021-12-31.xsd#TagsthatmustbeappliedifcorrespondinginformationispresentinareportStatement"/>
  <link:presentationLink xlink:role="http://www.pharming.com/role/TagsthatmustbeappliedifcorrespondinginformationispresentinareportStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_esef_cor_NotesAccountingPoliciesAndMandatoryTags_ad3b1122-d921-4c54-b00c-8c0a06d23eeb" xlink:href="http://www.esma.europa.eu/taxonomy/2020-03-16/esef_cor.xsd#esef_cor_NotesAccountingPoliciesAndMandatoryTags"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NameOfReportingEntityOrOtherMeansOfIdentification_5bc46797-edfd-4945-b658-5d1a8b55e1f5" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NameOfReportingEntityOrOtherMeansOfIdentification"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esef_cor_NotesAccountingPoliciesAndMandatoryTags_ad3b1122-d921-4c54-b00c-8c0a06d23eeb" xlink:to="loc_ifrs-full_NameOfReportingEntityOrOtherMeansOfIdentification_5bc46797-edfd-4945-b658-5d1a8b55e1f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NameOfUltimateParentOfGroup_d339e229-4ff3-4ef6-b0cd-ae8b6cbc9e22" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NameOfUltimateParentOfGroup"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esef_cor_NotesAccountingPoliciesAndMandatoryTags_ad3b1122-d921-4c54-b00c-8c0a06d23eeb" xlink:to="loc_ifrs-full_NameOfUltimateParentOfGroup_d339e229-4ff3-4ef6-b0cd-ae8b6cbc9e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LegalFormOfEntity_e38bfee2-0d1c-4f8c-9ba3-1535c10ea301" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LegalFormOfEntity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esef_cor_NotesAccountingPoliciesAndMandatoryTags_ad3b1122-d921-4c54-b00c-8c0a06d23eeb" xlink:to="loc_ifrs-full_LegalFormOfEntity_e38bfee2-0d1c-4f8c-9ba3-1535c10ea301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AddressOfRegisteredOfficeOfEntity_9d7422cb-b85c-4970-bda2-5b8b36d3edde" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AddressOfRegisteredOfficeOfEntity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esef_cor_NotesAccountingPoliciesAndMandatoryTags_ad3b1122-d921-4c54-b00c-8c0a06d23eeb" xlink:to="loc_ifrs-full_AddressOfRegisteredOfficeOfEntity_9d7422cb-b85c-4970-bda2-5b8b36d3edde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CountryOfIncorporation_60d3eb42-d6e1-4add-9722-937f7d6f6ec3" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CountryOfIncorporation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esef_cor_NotesAccountingPoliciesAndMandatoryTags_ad3b1122-d921-4c54-b00c-8c0a06d23eeb" xlink:to="loc_ifrs-full_CountryOfIncorporation_60d3eb42-d6e1-4add-9722-937f7d6f6ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PrincipalPlaceOfBusiness_23da9a8f-37bb-4339-adc1-dc6c4881dead" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PrincipalPlaceOfBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esef_cor_NotesAccountingPoliciesAndMandatoryTags_ad3b1122-d921-4c54-b00c-8c0a06d23eeb" xlink:to="loc_ifrs-full_PrincipalPlaceOfBusiness_23da9a8f-37bb-4339-adc1-dc6c4881dead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DomicileOfEntity_cff66411-c617-41e3-9745-5aff67e3622a" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DomicileOfEntity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esef_cor_NotesAccountingPoliciesAndMandatoryTags_ad3b1122-d921-4c54-b00c-8c0a06d23eeb" xlink:to="loc_ifrs-full_DomicileOfEntity_cff66411-c617-41e3-9745-5aff67e3622a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_1d5dec0c-b5f5-419a-a9fe-9d418f639fa1" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esef_cor_NotesAccountingPoliciesAndMandatoryTags_ad3b1122-d921-4c54-b00c-8c0a06d23eeb" xlink:to="loc_ifrs-full_DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities_1d5dec0c-b5f5-419a-a9fe-9d418f639fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pharming.com/role/StatementofcomprehensiveincomeprofitorlossbyfunctionofexpenseStatement" xlink:type="simple" xlink:href="pharm-2021-12-31.xsd#StatementofcomprehensiveincomeprofitorlossbyfunctionofexpenseStatement"/>
  <link:presentationLink xlink:role="http://www.pharming.com/role/StatementofcomprehensiveincomeprofitorlossbyfunctionofexpenseStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Revenue_f2bcf8e3-79fe-4961-974f-4f931f5c773a" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Revenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_Revenue_f2bcf8e3-79fe-4961-974f-4f931f5c773a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_7deaa37d-fe54-4bfd-a496-a7b02268dcec" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CostOfSales"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_CostOfSales_7deaa37d-fe54-4bfd-a496-a7b02268dcec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit_185816a7-4455-46c6-a9be-8cf7859de38b" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_GrossProfit_185816a7-4455-46c6-a9be-8cf7859de38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIncome_805ca414-e403-4752-b431-49de8b8b4731" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_OtherIncome_805ca414-e403-4752-b431-49de8b8b4731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_fcd825b0-d0fc-4fb0-a1fa-ec7c4d4d3a90" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_fcd825b0-d0fc-4fb0-a1fa-ec7c4d4d3a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdministrativeExpense_d5670586-adcd-4233-a828-c3ddb9c99777" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdministrativeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_AdministrativeExpense_d5670586-adcd-4233-a828-c3ddb9c99777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_1104ac52-f83d-4db1-b72b-fd53b9444879" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_1104ac52-f83d-4db1-b72b-fd53b9444879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherExpenseByFunction_c4afd975-6fe7-4a84-b1aa-9ee966233300" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherExpenseByFunction"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_OtherExpenseByFunction_c4afd975-6fe7-4a84-b1aa-9ee966233300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_0c075f66-0a87-4e71-9698-e6c3aefb0db0" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_0c075f66-0a87-4e71-9698-e6c3aefb0db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_2277816c-49ae-4574-b080-ac23a8dcf8c8" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_2277816c-49ae-4574-b080-ac23a8dcf8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_4dfaa89f-ae4f-4ee8-8f7b-5dab3a188be2" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncome"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_FinanceIncome_4dfaa89f-ae4f-4ee8-8f7b-5dab3a188be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_9c05a24f-ce77-4680-a2c6-1caf74857f07" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_FinanceCosts_9c05a24f-ce77-4680-a2c6-1caf74857f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost_626cd9e9-d821-44ba-9a48-c60d6c59d715" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_FinanceIncomeCost_626cd9e9-d821-44ba-9a48-c60d6c59d715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_12fcdd27-89d3-48c1-9f51-dd7299d89964" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_12fcdd27-89d3-48c1-9f51-dd7299d89964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_6e857ace-ffce-4f63-be06-240a0e4ed165" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_6e857ace-ffce-4f63-be06-240a0e4ed165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_601f3943-6cc2-44a8-8233-68fca121869d" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_601f3943-6cc2-44a8-8233-68fca121869d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_72b9efbe-9c17-4b7b-bb61-557544c4117d" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_ProfitLoss_72b9efbe-9c17-4b7b-bb61-557544c4117d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_ac492462-4c37-4d39-aa0e-1f6adca6af1b" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_ac492462-4c37-4d39-aa0e-1f6adca6af1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_ec99b155-3128-442a-b692-3a4e3dd89efe" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_8c422d06-d3d4-44b6-b0f1-c00a9795af1d" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShare_ec99b155-3128-442a-b692-3a4e3dd89efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pharming.com/role/StatementofcomprehensiveincomeOCIcomponentspresentednetoftaxStatement" xlink:type="simple" xlink:href="pharm-2021-12-31.xsd#StatementofcomprehensiveincomeOCIcomponentspresentednetoftaxStatement"/>
  <link:presentationLink xlink:role="http://www.pharming.com/role/StatementofcomprehensiveincomeOCIcomponentspresentednetoftaxStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_4b47c092-7977-453e-aa1e-40c26016bf93" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_4f160dbd-ed03-46ed-8b7a-cebc5bf87f0a" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_4b47c092-7977-453e-aa1e-40c26016bf93" xlink:to="loc_ifrs-full_ProfitLoss_4f160dbd-ed03-46ed-8b7a-cebc5bf87f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_f07f99be-5b80-42f7-8806-8b2d53b00870" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_4b47c092-7977-453e-aa1e-40c26016bf93" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_f07f99be-5b80-42f7-8806-8b2d53b00870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments_eba62400-1cdb-40e1-98f9-a72393ebc4b1" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_4b47c092-7977-453e-aa1e-40c26016bf93" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments_eba62400-1cdb-40e1-98f9-a72393ebc4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_aeb4061f-f4a0-4429-bb6b-32e3eed97769" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_4b47c092-7977-453e-aa1e-40c26016bf93" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_aeb4061f-f4a0-4429-bb6b-32e3eed97769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_8ae68c53-577c-4993-ab22-1b3421837656" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_4b47c092-7977-453e-aa1e-40c26016bf93" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_8ae68c53-577c-4993-ab22-1b3421837656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_288d5a1d-8486-42e9-b1fe-b1f875f51593" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_4b47c092-7977-453e-aa1e-40c26016bf93" xlink:to="loc_ifrs-full_ComprehensiveIncome_288d5a1d-8486-42e9-b1fe-b1f875f51593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pharming.com/role/StatementoffinancialpositioncurrentnoncurrentStatement" xlink:type="simple" xlink:href="pharm-2021-12-31.xsd#StatementoffinancialpositioncurrentnoncurrentStatement"/>
  <link:presentationLink xlink:role="http://www.pharming.com/role/StatementoffinancialpositioncurrentnoncurrentStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_9c2f6d35-be13-4a15-886b-d3be262aafb8" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAbstract_0e05b58b-a770-48d4-94a4-37abc487676e" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_9c2f6d35-be13-4a15-886b-d3be262aafb8" xlink:to="loc_ifrs-full_AssetsAbstract_0e05b58b-a770-48d4-94a4-37abc487676e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_3fd4fa10-7d5b-49ed-919c-eb52827dc3dd" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_0e05b58b-a770-48d4-94a4-37abc487676e" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_3fd4fa10-7d5b-49ed-919c-eb52827dc3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_0857ca08-67b2-49de-9a33-4b99e2453274" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_3fd4fa10-7d5b-49ed-919c-eb52827dc3dd" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_0857ca08-67b2-49de-9a33-4b99e2453274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_035a15eb-0c7a-43cf-9018-d3ea5f2fb7d4" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_3fd4fa10-7d5b-49ed-919c-eb52827dc3dd" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_035a15eb-0c7a-43cf-9018-d3ea5f2fb7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_988f9329-2406-40a1-b9fe-79575b84fa03" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RightofuseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_3fd4fa10-7d5b-49ed-919c-eb52827dc3dd" xlink:to="loc_ifrs-full_RightofuseAssets_988f9329-2406-40a1-b9fe-79575b84fa03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentPrepayments_7f6404c1-3416-4f32-80ef-8138b18ff2df" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentPrepayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_3fd4fa10-7d5b-49ed-919c-eb52827dc3dd" xlink:to="loc_ifrs-full_NoncurrentPrepayments_7f6404c1-3416-4f32-80ef-8138b18ff2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_8d205f7f-4a7b-4a86-83ea-0539b57bad84" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_3fd4fa10-7d5b-49ed-919c-eb52827dc3dd" xlink:to="loc_ifrs-full_DeferredTaxAssets_8d205f7f-4a7b-4a86-83ea-0539b57bad84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_a3d070ba-8a5e-48a8-b6da-a74df532caa0" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_3fd4fa10-7d5b-49ed-919c-eb52827dc3dd" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_a3d070ba-8a5e-48a8-b6da-a74df532caa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentInvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncome_af4546d6-d30d-4ef1-aea8-ef649db835f7" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentInvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_3fd4fa10-7d5b-49ed-919c-eb52827dc3dd" xlink:to="loc_ifrs-full_NoncurrentInvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncome_af4546d6-d30d-4ef1-aea8-ef649db835f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_c85214ef-072b-42aa-a56c-08b1653cd924" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentRestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_3fd4fa10-7d5b-49ed-919c-eb52827dc3dd" xlink:to="loc_ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_c85214ef-072b-42aa-a56c-08b1653cd924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_28fb68f5-0dda-477d-b3f5-9a89484559e0" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_3fd4fa10-7d5b-49ed-919c-eb52827dc3dd" xlink:to="loc_ifrs-full_NoncurrentAssets_28fb68f5-0dda-477d-b3f5-9a89484559e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_10a5350b-eaf4-4470-9ed7-c6694494bf68" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_0e05b58b-a770-48d4-94a4-37abc487676e" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_10a5350b-eaf4-4470-9ed7-c6694494bf68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories_beb7fb7c-0457-46dc-ad74-ec891c530d75" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Inventories"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_10a5350b-eaf4-4470-9ed7-c6694494bf68" xlink:to="loc_ifrs-full_Inventories_beb7fb7c-0457-46dc-ad74-ec891c530d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_3f551c9e-9260-40c9-a852-bce6cb2df0a8" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_10a5350b-eaf4-4470-9ed7-c6694494bf68" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_3f551c9e-9260-40c9-a852-bce6cb2df0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentRestrictedCashAndCashEquivalents_9d87df3f-9d3f-4bf0-8adf-0b0781b437a2" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentRestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_10a5350b-eaf4-4470-9ed7-c6694494bf68" xlink:to="loc_ifrs-full_CurrentRestrictedCashAndCashEquivalents_9d87df3f-9d3f-4bf0-8adf-0b0781b437a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_e8721f00-ddec-4649-a613-4125fe9260a9" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_10a5350b-eaf4-4470-9ed7-c6694494bf68" xlink:to="loc_ifrs-full_CashAndCashEquivalents_e8721f00-ddec-4649-a613-4125fe9260a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_1ae8e18c-95f6-4afd-82e8-042e495dd0f6" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_10a5350b-eaf4-4470-9ed7-c6694494bf68" xlink:to="loc_ifrs-full_CurrentAssets_1ae8e18c-95f6-4afd-82e8-042e495dd0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_a03bbaab-055d-497d-9911-221165566d2f" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_0e05b58b-a770-48d4-94a4-37abc487676e" xlink:to="loc_ifrs-full_Assets_a03bbaab-055d-497d-9911-221165566d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_97784794-f386-4949-bf85-d473e31ae98f" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_9c2f6d35-be13-4a15-886b-d3be262aafb8" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_97784794-f386-4949-bf85-d473e31ae98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_0217dd35-7ca2-485a-a777-917e311d69e7" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_97784794-f386-4949-bf85-d473e31ae98f" xlink:to="loc_ifrs-full_EquityAbstract_0217dd35-7ca2-485a-a777-917e311d69e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_cf959e94-1ad0-42f6-948b-03f0c54d4d2a" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapital"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_0217dd35-7ca2-485a-a777-917e311d69e7" xlink:to="loc_ifrs-full_IssuedCapital_cf959e94-1ad0-42f6-948b-03f0c54d4d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremium_7ddfc86a-7df6-4abd-a07b-d03f6fe2d04d" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharePremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_0217dd35-7ca2-485a-a777-917e311d69e7" xlink:to="loc_ifrs-full_SharePremium_7ddfc86a-7df6-4abd-a07b-d03f6fe2d04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReserves_54fa987f-8173-47ef-871c-a0c5563385e7" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_0217dd35-7ca2-485a-a777-917e311d69e7" xlink:to="loc_ifrs-full_OtherReserves_54fa987f-8173-47ef-871c-a0c5563385e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarnings_e20d8739-eff0-4649-be30-3530687fe7e7" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetainedEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_0217dd35-7ca2-485a-a777-917e311d69e7" xlink:to="loc_ifrs-full_RetainedEarnings_e20d8739-eff0-4649-be30-3530687fe7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_5fce1e31-b0aa-41c3-af92-135fa64c8d24" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_0217dd35-7ca2-485a-a777-917e311d69e7" xlink:to="loc_ifrs-full_Equity_5fce1e31-b0aa-41c3-af92-135fa64c8d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilitiesAbstract_f6f39f88-8feb-41d6-b5f1-ae86f0913a72" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_97784794-f386-4949-bf85-d473e31ae98f" xlink:to="loc_ifrs-full_LiabilitiesAbstract_f6f39f88-8feb-41d6-b5f1-ae86f0913a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_6a8c1eab-c0b6-44b8-bee4-b4cf6012b1a5" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_f6f39f88-8feb-41d6-b5f1-ae86f0913a72" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_6a8c1eab-c0b6-44b8-bee4-b4cf6012b1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued_7539b918-fa28-4d8c-bfcb-82fe44ce0a8f" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_6a8c1eab-c0b6-44b8-bee4-b4cf6012b1a5" xlink:to="loc_ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued_7539b918-fa28-4d8c-bfcb-82fe44ce0a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_20efb71b-d2b6-4341-ad31-e2791da76656" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_6a8c1eab-c0b6-44b8-bee4-b4cf6012b1a5" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_20efb71b-d2b6-4341-ad31-e2791da76656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_644bb817-662f-408f-9fb2-b8db6039bf18" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_6a8c1eab-c0b6-44b8-bee4-b4cf6012b1a5" xlink:to="loc_ifrs-full_OtherNoncurrentFinancialLiabilities_644bb817-662f-408f-9fb2-b8db6039bf18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_f1d28568-63c2-4dd8-a75d-ad187cc6c463" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_6a8c1eab-c0b6-44b8-bee4-b4cf6012b1a5" xlink:to="loc_ifrs-full_NoncurrentLiabilities_f1d28568-63c2-4dd8-a75d-ad187cc6c463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_98103d17-ece2-4c06-bd9e-b311145d6a35" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_f6f39f88-8feb-41d6-b5f1-ae86f0913a72" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_98103d17-ece2-4c06-bd9e-b311145d6a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued_6e761bd6-82de-46ff-931e-348efad81d0a" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_98103d17-ece2-4c06-bd9e-b311145d6a35" xlink:to="loc_ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued_6e761bd6-82de-46ff-931e-348efad81d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_52b527fe-70b4-4a03-98e1-60c3da76f49a" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_98103d17-ece2-4c06-bd9e-b311145d6a35" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_52b527fe-70b4-4a03-98e1-60c3da76f49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermBorrowings_7505bce7-35e5-4a5c-9b17-40696457ee63" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ShorttermBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_98103d17-ece2-4c06-bd9e-b311145d6a35" xlink:to="loc_ifrs-full_ShorttermBorrowings_7505bce7-35e5-4a5c-9b17-40696457ee63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_896f7165-8a01-4798-af7b-f1da201ea739" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_98103d17-ece2-4c06-bd9e-b311145d6a35" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_896f7165-8a01-4798-af7b-f1da201ea739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_da483418-2944-4de6-abff-5c83855ec639" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_98103d17-ece2-4c06-bd9e-b311145d6a35" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_da483418-2944-4de6-abff-5c83855ec639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentFinancialLiabilities_72cf1839-5560-4910-a964-fdfdd9c28804" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentFinancialLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_98103d17-ece2-4c06-bd9e-b311145d6a35" xlink:to="loc_ifrs-full_OtherCurrentFinancialLiabilities_72cf1839-5560-4910-a964-fdfdd9c28804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities_5319c7a5-3230-4609-bf7e-332555c196d6" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_98103d17-ece2-4c06-bd9e-b311145d6a35" xlink:to="loc_ifrs-full_CurrentLiabilities_5319c7a5-3230-4609-bf7e-332555c196d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilities_cfdf11e2-6996-401d-a07e-1c3f7a015ef3" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_97784794-f386-4949-bf85-d473e31ae98f" xlink:to="loc_ifrs-full_EquityAndLiabilities_cfdf11e2-6996-401d-a07e-1c3f7a015ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pharming.com/role/StatementofchangesinequityStatement" xlink:type="simple" xlink:href="pharm-2021-12-31.xsd#StatementofchangesinequityStatement"/>
  <link:presentationLink xlink:role="http://www.pharming.com/role/StatementofchangesinequityStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_9ab89976-6507-488f-acf6-756692d88c0e" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_549bcd35-3593-4bee-886f-6f44bd1a99b5" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_9ab89976-6507-488f-acf6-756692d88c0e" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_549bcd35-3593-4bee-886f-6f44bd1a99b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_06a436e4-b967-4338-bb07-95286a6ed4aa" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_549bcd35-3593-4bee-886f-6f44bd1a99b5" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_06a436e4-b967-4338-bb07-95286a6ed4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityMember_748dbbda-eb0a-458a-a412-c8d48683e2e0" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_06a436e4-b967-4338-bb07-95286a6ed4aa" xlink:to="loc_ifrs-full_EquityMember_748dbbda-eb0a-458a-a412-c8d48683e2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_8f4f1edf-40cd-4129-84fb-fbff4f593ec4" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_748dbbda-eb0a-458a-a412-c8d48683e2e0" xlink:to="loc_ifrs-full_IssuedCapitalMember_8f4f1edf-40cd-4129-84fb-fbff4f593ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_dba24e1d-782f-4e40-94c2-d544232137e0" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharePremiumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_748dbbda-eb0a-458a-a412-c8d48683e2e0" xlink:to="loc_ifrs-full_SharePremiumMember_dba24e1d-782f-4e40-94c2-d544232137e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevaluationSurplusMember_9768c24e-c3dd-4be5-88ab-bef1e944de8f" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RevaluationSurplusMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_748dbbda-eb0a-458a-a412-c8d48683e2e0" xlink:to="loc_ifrs-full_RevaluationSurplusMember_9768c24e-c3dd-4be5-88ab-bef1e944de8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_pharm_ReserveParticipatingInterestMember_23e4c2aa-8d6d-421d-bec5-38482cbb85f2" xlink:href="pharm-2021-12-31.xsd#pharm_ReserveParticipatingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_748dbbda-eb0a-458a-a412-c8d48683e2e0" xlink:to="loc_pharm_ReserveParticipatingInterestMember_23e4c2aa-8d6d-421d-bec5-38482cbb85f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_pharm_CapitalizedDevelopmentCostReserveMember_5c8b3981-bccf-4f9b-b490-ccfdcfb3cfa7" xlink:href="pharm-2021-12-31.xsd#pharm_CapitalizedDevelopmentCostReserveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_748dbbda-eb0a-458a-a412-c8d48683e2e0" xlink:to="loc_pharm_CapitalizedDevelopmentCostReserveMember_5c8b3981-bccf-4f9b-b490-ccfdcfb3cfa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_b1e31d73-4e5f-42bc-af9c-e113631ac503" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_748dbbda-eb0a-458a-a412-c8d48683e2e0" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_b1e31d73-4e5f-42bc-af9c-e113631ac503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsMember_716d954f-7fac-4b75-a5f2-7a793cd5489a" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetainedEarningsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_748dbbda-eb0a-458a-a412-c8d48683e2e0" xlink:to="loc_ifrs-full_RetainedEarningsMember_716d954f-7fac-4b75-a5f2-7a793cd5489a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_540df377-ef0b-4368-801e-15f41b8010c9" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_549bcd35-3593-4bee-886f-6f44bd1a99b5" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_540df377-ef0b-4368-801e-15f41b8010c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_ddff65f3-83e3-4c80-a08e-ff8997342dff" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_540df377-ef0b-4368-801e-15f41b8010c9" xlink:to="loc_ifrs-full_Equity_ddff65f3-83e3-4c80-a08e-ff8997342dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAbstract_56183583-c4dc-4a13-bc1d-930f3eb03a3c" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncomeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_540df377-ef0b-4368-801e-15f41b8010c9" xlink:to="loc_ifrs-full_ComprehensiveIncomeAbstract_56183583-c4dc-4a13-bc1d-930f3eb03a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_a832906c-e99f-40c6-be17-e9ebbddfe12b" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComprehensiveIncomeAbstract_56183583-c4dc-4a13-bc1d-930f3eb03a3c" xlink:to="loc_ifrs-full_ProfitLoss_a832906c-e99f-40c6-be17-e9ebbddfe12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_0589e6f9-0e18-4373-8b5d-be8d24939f6c" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComprehensiveIncomeAbstract_56183583-c4dc-4a13-bc1d-930f3eb03a3c" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_0589e6f9-0e18-4373-8b5d-be8d24939f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_e03da286-a2f6-497d-a2a2-c26b11c1bf42" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComprehensiveIncomeAbstract_56183583-c4dc-4a13-bc1d-930f3eb03a3c" xlink:to="loc_ifrs-full_ComprehensiveIncome_e03da286-a2f6-497d-a2a2-c26b11c1bf42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransferToStatutoryReserve_45f1a916-b0b4-4698-a3ca-7757ba425872" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughTransferToStatutoryReserve"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_540df377-ef0b-4368-801e-15f41b8010c9" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransferToStatutoryReserve_45f1a916-b0b4-4698-a3ca-7757ba425872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions_b1c72dd3-0746-4002-8626-4c141518795a" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_540df377-ef0b-4368-801e-15f41b8010c9" xlink:to="loc_ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions_b1c72dd3-0746-4002-8626-4c141518795a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_97330b85-582a-4f35-bc8a-f613d7f5e962" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_540df377-ef0b-4368-801e-15f41b8010c9" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_97330b85-582a-4f35-bc8a-f613d7f5e962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_pharm_BonusesSettledInShares_846d66aa-40cf-4f1e-ac48-8e4b1529bc72" xlink:href="pharm-2021-12-31.xsd#pharm_BonusesSettledInShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_540df377-ef0b-4368-801e-15f41b8010c9" xlink:to="loc_pharm_BonusesSettledInShares_846d66aa-40cf-4f1e-ac48-8e4b1529bc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_73655883-61bd-4e58-a2d8-390ae461fc92" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_540df377-ef0b-4368-801e-15f41b8010c9" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_73655883-61bd-4e58-a2d8-390ae461fc92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_2773cb6b-dd78-4573-9e3d-e2db224f8564" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_540df377-ef0b-4368-801e-15f41b8010c9" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_2773cb6b-dd78-4573-9e3d-e2db224f8564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_pharm_OptionsExercisedAndLtipSharesIssued_9c21cfaf-7b2f-4c9d-a88d-f4bfc49a0e9e" xlink:href="pharm-2021-12-31.xsd#pharm_OptionsExercisedAndLtipSharesIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_540df377-ef0b-4368-801e-15f41b8010c9" xlink:to="loc_pharm_OptionsExercisedAndLtipSharesIssued_9c21cfaf-7b2f-4c9d-a88d-f4bfc49a0e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_pharm_TotalTransactionsWithOwnersRecognizedDirectlyInEquity_433cde39-4525-468e-912a-7429ab6124bb" xlink:href="pharm-2021-12-31.xsd#pharm_TotalTransactionsWithOwnersRecognizedDirectlyInEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_540df377-ef0b-4368-801e-15f41b8010c9" xlink:to="loc_pharm_TotalTransactionsWithOwnersRecognizedDirectlyInEquity_433cde39-4525-468e-912a-7429ab6124bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_ce7a943d-1a98-4b98-8a3c-bdefec2ac158" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_540df377-ef0b-4368-801e-15f41b8010c9" xlink:to="loc_ifrs-full_Equity_ce7a943d-1a98-4b98-8a3c-bdefec2ac158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pharming.com/role/StatementofcashflowsindirectmethodStatement" xlink:type="simple" xlink:href="pharm-2021-12-31.xsd#StatementofcashflowsindirectmethodStatement"/>
  <link:presentationLink xlink:role="http://www.pharming.com/role/StatementofcashflowsindirectmethodStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_33095f7f-a2f1-4a2a-abd1-57604fcce294" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_70b56d2c-96d0-4410-9ba1-ebb898d5ea08" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_33095f7f-a2f1-4a2a-abd1-57604fcce294" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_70b56d2c-96d0-4410-9ba1-ebb898d5ea08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_11a16e03-ffae-4e07-abd2-382039b7379e" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_70b56d2c-96d0-4410-9ba1-ebb898d5ea08" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_11a16e03-ffae-4e07-abd2-382039b7379e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_932744b2-ab33-463f-b6a5-e9fc37770a4d" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_70b56d2c-96d0-4410-9ba1-ebb898d5ea08" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_932744b2-ab33-463f-b6a5-e9fc37770a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_f7371554-ecd8-4cdb-9d1f-00460c05b9ca" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_932744b2-ab33-463f-b6a5-e9fc37770a4d" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_f7371554-ecd8-4cdb-9d1f-00460c05b9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_59f1c6a6-a1c9-4d5c-8aba-220c3d47c4c5" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_932744b2-ab33-463f-b6a5-e9fc37770a4d" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_59f1c6a6-a1c9-4d5c-8aba-220c3d47c4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_2d087b9d-9975-471c-9a6a-1a2ca79eefd1" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_932744b2-ab33-463f-b6a5-e9fc37770a4d" xlink:to="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_2d087b9d-9975-471c-9a6a-1a2ca79eefd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncome_14fd4607-d5ef-4c40-81f1-b0f0d0363c90" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForFinanceIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_932744b2-ab33-463f-b6a5-e9fc37770a4d" xlink:to="loc_ifrs-full_AdjustmentsForFinanceIncome_14fd4607-d5ef-4c40-81f1-b0f0d0363c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForFinanceCosts_e7bc0eda-3212-465a-9a98-0846cc3c59ec" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForFinanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_932744b2-ab33-463f-b6a5-e9fc37770a4d" xlink:to="loc_ifrs-full_AdjustmentsForFinanceCosts_e7bc0eda-3212-465a-9a98-0846cc3c59ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates_4bab3e6c-7d47-4646-ae10-ae68c180821d" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_932744b2-ab33-463f-b6a5-e9fc37770a4d" xlink:to="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates_4bab3e6c-7d47-4646-ae10-ae68c180821d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAdjustmentsForNoncashItems_5d6415c7-ac83-46b8-850b-cee13e8eb688" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherAdjustmentsForNoncashItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_932744b2-ab33-463f-b6a5-e9fc37770a4d" xlink:to="loc_ifrs-full_OtherAdjustmentsForNoncashItems_5d6415c7-ac83-46b8-850b-cee13e8eb688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_66c96a96-b438-4155-bb55-359afa0d40e1" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_932744b2-ab33-463f-b6a5-e9fc37770a4d" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_66c96a96-b438-4155-bb55-359afa0d40e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_52008fc2-a6d0-46f6-8057-4ec5f54bc8ac" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_932744b2-ab33-463f-b6a5-e9fc37770a4d" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_52008fc2-a6d0-46f6-8057-4ec5f54bc8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_89731ed1-e7df-472c-b34a-13ca336aa622" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_932744b2-ab33-463f-b6a5-e9fc37770a4d" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_89731ed1-e7df-472c-b34a-13ca336aa622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_aacbe47d-60a2-4413-b031-51a80bf34282" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_932744b2-ab33-463f-b6a5-e9fc37770a4d" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_aacbe47d-60a2-4413-b031-51a80bf34282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents_32b5f881-82b1-4ac1-8b18-2a032dc70507" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_932744b2-ab33-463f-b6a5-e9fc37770a4d" xlink:to="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents_32b5f881-82b1-4ac1-8b18-2a032dc70507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_27244e27-c2bf-4f28-93ef-bdf101dc6d2d" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_932744b2-ab33-463f-b6a5-e9fc37770a4d" xlink:to="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_27244e27-c2bf-4f28-93ef-bdf101dc6d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_3286b7ad-66b8-4539-9227-eb245986293e" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_70b56d2c-96d0-4410-9ba1-ebb898d5ea08" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_3286b7ad-66b8-4539-9227-eb245986293e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_ec2d27a3-3f8d-42e2-afc8-866807ece310" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_70b56d2c-96d0-4410-9ba1-ebb898d5ea08" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_ec2d27a3-3f8d-42e2-afc8-866807ece310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_015a2ff1-c115-4b94-ad95-20c4a6f9c516" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_70b56d2c-96d0-4410-9ba1-ebb898d5ea08" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_015a2ff1-c115-4b94-ad95-20c4a6f9c516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_d11aee30-b5e0-4c52-83eb-2a4f3d68739f" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_33095f7f-a2f1-4a2a-abd1-57604fcce294" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_d11aee30-b5e0-4c52-83eb-2a4f3d68739f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_a9420502-c6fb-4cf3-921e-ea01912da343" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_d11aee30-b5e0-4c52-83eb-2a4f3d68739f" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_a9420502-c6fb-4cf3-921e-ea01912da343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_c32ecc06-b04b-4285-bbcf-6c9280830763" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_d11aee30-b5e0-4c52-83eb-2a4f3d68739f" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_c32ecc06-b04b-4285-bbcf-6c9280830763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfInterestsInAssociates_f6def528-18a0-4e81-9bbd-e2e02abfbbdf" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfInterestsInAssociates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_d11aee30-b5e0-4c52-83eb-2a4f3d68739f" xlink:to="loc_ifrs-full_PurchaseOfInterestsInAssociates_f6def528-18a0-4e81-9bbd-e2e02abfbbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_0babd76d-ba33-47f2-88b0-734face534b6" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_d11aee30-b5e0-4c52-83eb-2a4f3d68739f" xlink:to="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_0babd76d-ba33-47f2-88b0-734face534b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsForDevelopmentProjectExpenditure_750b77c2-7426-4501-8a17-19fa89f410fd" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsForDevelopmentProjectExpenditure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_d11aee30-b5e0-4c52-83eb-2a4f3d68739f" xlink:to="loc_ifrs-full_PaymentsForDevelopmentProjectExpenditure_750b77c2-7426-4501-8a17-19fa89f410fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_efcbaea1-8919-4901-8eae-fa93091d2e92" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_d11aee30-b5e0-4c52-83eb-2a4f3d68739f" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_efcbaea1-8919-4901-8eae-fa93091d2e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_373cd0e7-8ba8-48a0-b6b5-46488258dcf9" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_33095f7f-a2f1-4a2a-abd1-57604fcce294" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_373cd0e7-8ba8-48a0-b6b5-46488258dcf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_86eb8600-0b74-4138-aa5d-9e682588555c" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_373cd0e7-8ba8-48a0-b6b5-46488258dcf9" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_86eb8600-0b74-4138-aa5d-9e682588555c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_pharm_PaymentOnContingentConsideration_7d7d6bf1-cff7-43f3-8bfb-913e58487a95" xlink:href="pharm-2021-12-31.xsd#pharm_PaymentOnContingentConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_373cd0e7-8ba8-48a0-b6b5-46488258dcf9" xlink:to="loc_pharm_PaymentOnContingentConsideration_7d7d6bf1-cff7-43f3-8bfb-913e58487a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_c1894f0f-eb40-41c5-ae93-73eabd1297e4" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_373cd0e7-8ba8-48a0-b6b5-46488258dcf9" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_c1894f0f-eb40-41c5-ae93-73eabd1297e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_df4f9cfd-e6e4-457a-b188-1c3745670568" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_373cd0e7-8ba8-48a0-b6b5-46488258dcf9" xlink:to="loc_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_df4f9cfd-e6e4-457a-b188-1c3745670568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsForDebtIssueCosts_f52785eb-0917-4060-9fa0-176f7d98c5e6" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsForDebtIssueCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_373cd0e7-8ba8-48a0-b6b5-46488258dcf9" xlink:to="loc_ifrs-full_PaymentsForDebtIssueCosts_f52785eb-0917-4060-9fa0-176f7d98c5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_514242f9-4c4a-4327-ac92-f9c2ac823e19" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_373cd0e7-8ba8-48a0-b6b5-46488258dcf9" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_514242f9-4c4a-4327-ac92-f9c2ac823e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_80744c15-15b0-4fc3-a736-87031943a72b" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_373cd0e7-8ba8-48a0-b6b5-46488258dcf9" xlink:to="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_80744c15-15b0-4fc3-a736-87031943a72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_79688761-22ad-4bd7-bb59-14be0ffd8ad6" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_373cd0e7-8ba8-48a0-b6b5-46488258dcf9" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_79688761-22ad-4bd7-bb59-14be0ffd8ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_0e492042-4a45-400c-9454-114218f5712c" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_33095f7f-a2f1-4a2a-abd1-57604fcce294" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_0e492042-4a45-400c-9454-114218f5712c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalentsAbstract_f2e8ff8f-b2c4-4ada-b200-c8aee9332cea" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalentsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_33095f7f-a2f1-4a2a-abd1-57604fcce294" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalentsAbstract_f2e8ff8f-b2c4-4ada-b200-c8aee9332cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_ab1dda6f-247a-4968-b9ad-bf0c829c430b" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalentsAbstract_f2e8ff8f-b2c4-4ada-b200-c8aee9332cea" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_ab1dda6f-247a-4968-b9ad-bf0c829c430b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_0586b1b2-972c-418c-bb22-6f1fa00e399a" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_33095f7f-a2f1-4a2a-abd1-57604fcce294" xlink:to="loc_ifrs-full_CashAndCashEquivalents_0586b1b2-972c-418c-bb22-6f1fa00e399a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_77f4b226-82af-45c4-aa64-133b3d6f46a4" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_33095f7f-a2f1-4a2a-abd1-57604fcce294" xlink:to="loc_ifrs-full_CashAndCashEquivalents_77f4b226-82af-45c4-aa64-133b3d6f46a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
